Low-cost HPV test that gives same-day results and treatment in women 30-59

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a low-cost, locally processable HPV test (ScreenFire) for cervical cancer screening. The trial uses a same-day screen-and-treat approach, allowing immediate follow-up actions if needed. Eligible participants are women aged 30-59 who agree to self-collect an HPV sample; those with prior hysterectomy or recent HPV testing are excluded. The study is conducted at Ministry of Health clinics in San Salvador, led by The Cleveland Clinic, to determine efficacy and potential cost-effectiveness in LMIC settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women between 30-59 years of age
* Willing to conduct HPV self-sampling

Exclusion Criteria:

* Prior hysterectomy
* HPV testing in at least 5 years
* Previous diagnosis or treatment of invasive cancer

Where it's running

• Ministry of Health Clinics
  San Salvador, Oriente, El Salvador Recruiting

Study contacts

• Principal investigator: Miriam Cremer, MD — The Cleveland Clinic
• Study coordinator: Miriam Cremer, MD
• Email: cremerm@ccf.org
• Phone: 216-213-6460

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of cervical cancer after HPV detection in healthy women

  This study tests how likely it is for cervical cancer to develop after different HPV detection patterns in healthy women who undergo HPV-based screening.

  Recruiting Karolinska Institutet · Stockholm · NCT07850128

• Routine shallow-coverage Whole Genome Sequencing of Cervical Smears to See if Ovarian Cancer is Found Earlier

  Researchers test whether analyzing DNA from cervical smears with shallow whole-genome sequencing can help detect high-grade serous ovarian cancer early in patients undergoing treatment for this cancer.

  Recruiting Institut Claudius Regaud · Toulouse · NCT07821879

• HPV self-sampling in the ED to screen under-screened women

  This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.

  Recruiting Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT07657104

• Self-sampling HPV screening offered in the emergency department

  This project tests whether offering HPV self-sampling in the emergency department helps more people aged 30–65 with a cervix get screened for cervical cancer.

  Recruiting University of Rochester · Rochester, New York · NCT07345897

• Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers

  This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.

  Recruiting at 2 sites Tata Memorial Hospital · Mumbai, Maharashtra and 1 other locations · NCT07290972

• Q-Pad menstrual-pad test to detect high-risk HPV and cervical precancer

  This study tests whether a home menstrual-pad kit (Q-Pad) can detect high-risk HPV and cervical precancer in people referred for colposcopy after an abnormal Pap or HPV result.

  Recruiting at 3 sites Qurasense · New Haven, Connecticut and 2 other locations · NCT07281599

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.